{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T13:32:18Z","timestamp":1789047138448,"version":"build-2803163510"},"reference-count":108,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"NIH\/NIA","award":["R37AG037319"],"award-info":[{"award-number":["R37AG037319"]}]},{"name":"NIH\/NIA","award":["R01AG044793"],"award-info":[{"award-number":["R01AG044793"]}]},{"name":"NIH\/NIA","award":["R01AG053041"],"award-info":[{"award-number":["R01AG053041"]}]},{"name":"NIH\/NIA","award":["R01AG054320"],"award-info":[{"award-number":["R01AG054320"]}]},{"name":"NIH\/NINDS","award":["R01NS089116"],"award-info":[{"award-number":["R01NS089116"]}]}],"content-domain":{"domain":["bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Discovery Today"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.drudis.2018.08.001","type":"journal-article","created":{"date-parts":[[2018,8,3]],"date-time":"2018-08-03T13:06:41Z","timestamp":1533301601000},"page":"1983-1989","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":110,"title":["Mitochondrial permeability transition pore: a potential drug target for neurodegeneration"],"prefix":"10.1016","volume":"23","author":[{"given":"Komal","family":"Kalani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi Fang","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shirley ShiDu","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl. 1","key":"10.1016\/j.drudis.2018.08.001_bib0005","doi-asserted-by":"crossref","first-page":"S96","DOI":"10.2337\/diabetes.53.2007.S96","article-title":"Roles of mitochondria in health and disease","volume":"53","author":"Duchen","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.drudis.2018.08.001_bib0010","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.ydbio.2004.07.026","article-title":"Early neural cell death: dying to become neurons","volume":"274","author":"Yeo","year":"2004","journal-title":"Dev. Biol."},{"key":"10.1016\/j.drudis.2018.08.001_bib0015","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2013.220","article-title":"Mature neurons: equipped for survival","volume":"4","author":"Kole","year":"2013","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.drudis.2018.08.001_bib0020","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.bbadis.2009.07.005","article-title":"Mitochondrial permeability transition pore in Alzheimer\u2019s disease: cyclophilin D and amyloid beta","volume":"1802","author":"Du","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.drudis.2018.08.001_bib0025","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/j.bbadis.2013.09.003","article-title":"Mitochondrial permeability transition pore is a potential drug target for neurodegeneration","volume":"1842","author":"Rao","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.drudis.2018.08.001_bib0030","doi-asserted-by":"crossref","first-page":"5069","DOI":"10.1016\/S0021-9258(17)33220-9","article-title":"Relationship between configuration, function, and permeability in calcium-treated mitochondria","volume":"251","author":"Hunter","year":"1976","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drudis.2018.08.001_bib0035","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/j.bbabio.2009.06.009","article-title":"Mitochondrial calcium and the permeability transition in cell death","volume":"1787","author":"Lemasters","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.drudis.2018.08.001_bib0040","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/0003-9861(79)90372-2","article-title":"The Ca2+-induced membrane transition in mitochondria. II. Nature of the Ca2+ trigger site","volume":"195","author":"Haworth","year":"1979","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.drudis.2018.08.001_bib0045","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3389\/fphys.2013.00095","article-title":"The mitochondrial permeability transition pore: a mystery solved?","volume":"4","author":"Bernardi","year":"2013","journal-title":"Front. Physiol."},{"key":"10.1016\/j.drudis.2018.08.001_bib0050","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0304-4157(95)00003-A","article-title":"The mitochondrial permeability transition","volume":"1241","author":"Zoratti","year":"1995","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.drudis.2018.08.001_bib0055","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1042\/bss0660181","article-title":"The mitochondrial permeability transition: its molecular mechanism and role in reperfusion injury","volume":"66","author":"Halestrap","year":"1999","journal-title":"Biochem. Soc. Symp."},{"key":"10.1016\/j.drudis.2018.08.001_bib0060","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/0014-5793(93)80274-X","article-title":"The mitochondrial permeability transition pore may comprise VDAC molecules. II. The electrophysiological properties of VDAC are compatible with those of the mitochondrial megachannel","volume":"330","author":"Szabo","year":"1993","journal-title":"FEBS Lett."},{"key":"10.1016\/j.drudis.2018.08.001_bib0065","doi-asserted-by":"crossref","first-page":"3346","DOI":"10.1074\/jbc.272.6.3346","article-title":"Oxidative stress, thiol reagents, and membrane potential modulate the mitochondrial permeability transition by affecting nucleotide binding to the adenine nucleotide translocase","volume":"272","author":"Halestrap","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drudis.2018.08.001_bib0070","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1016\/j.bbamcr.2016.02.012","article-title":"The mitochondrial permeability transition pore in AD 2016: an update","volume":"1863","author":"Biasutto","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.drudis.2018.08.001_bib0075","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1038\/nature03434","article-title":"Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death","volume":"434","author":"Baines","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2018.08.001_bib0080","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1038\/sj.cdd.4401963","article-title":"Mitochondrial outer membrane permeabilization during apoptosis: the innocent bystander scenario","volume":"13","author":"Chipuk","year":"2006","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.drudis.2018.08.001_bib0085","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1042\/bj3410233","article-title":"The mitochondrial permeability transition pore and its role in cell death","volume":"341","author":"Crompton","year":"1999","journal-title":"Biochem. J."},{"key":"10.1016\/j.drudis.2018.08.001_bib0090","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.yjmcc.2014.08.015","article-title":"Molecular identity of the mitochondrial permeability transition pore and its role in ischemia-reperfusion injury","volume":"78","author":"Morciano","year":"2015","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.drudis.2018.08.001_bib0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ydbio.2017.04.018","article-title":"Development or disease: duality of the mitochondrial permeability transition pore","volume":"426","author":"Perez","year":"2017","journal-title":"Dev. Biol."},{"key":"10.1016\/j.drudis.2018.08.001_bib0100","doi-asserted-by":"crossref","first-page":"16070","DOI":"10.1038\/cddiscovery.2016.70","article-title":"Mitochondrial permeability transition pore induction is linked to formation of the complex of ATPase C-subunit, polyhydroxybutyrate and inorganic polyphosphate","volume":"2","author":"Elustondo","year":"2016","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.drudis.2018.08.001_bib0105","doi-asserted-by":"crossref","first-page":"10580","DOI":"10.1073\/pnas.1401591111","article-title":"An uncoupling channel within the c-subunit ring of the F1FO ATP synthase is the mitochondrial permeability transition pore","volume":"111","author":"Alavian","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.drudis.2018.08.001_bib0110","doi-asserted-by":"crossref","first-page":"674","DOI":"10.4161\/cc.23599","article-title":"Role of the c subunit of the FO ATP synthase in mitochondrial permeability transition","volume":"12","author":"Bonora","year":"2013","journal-title":"Cell Cycle"},{"key":"10.1016\/j.drudis.2018.08.001_bib0115","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.15252\/embr.201643602","article-title":"Mitochondrial permeability transition involves dissociation of F1FO ATP synthase dimers and C-ring conformation","volume":"18","author":"Bonora","year":"2017","journal-title":"EMBO Rep."},{"key":"10.1016\/j.drudis.2018.08.001_bib0120","doi-asserted-by":"crossref","first-page":"3482","DOI":"10.2337\/db16-0556","article-title":"F1F0 ATP synthase-cyclophilin D interaction contributes to diabetes-induced synaptic dysfunction and cognitive decline","volume":"65","author":"Yan","year":"2016","journal-title":"Diabetes"},{"key":"10.1016\/j.drudis.2018.08.001_bib0125","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1016\/j.cell.2012.05.014","article-title":"p53 opens the mitochondrial permeability transition pore to trigger necrosis","volume":"149","author":"Vaseva","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.drudis.2018.08.001_bib0130","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ab.2017.07.006","article-title":"Osmotic regulation of the mitochondrial permeability transition pore investigated by light scattering, fluorescence and electron microscopy techniques","volume":"552","author":"Baev","year":"2017","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.drudis.2018.08.001_bib0135","doi-asserted-by":"crossref","first-page":"26312","DOI":"10.1074\/jbc.M805235200","article-title":"The mitochondrial phosphate carrier interacts with cyclophilin D and may play a key role in the permeability transition","volume":"283","author":"Leung","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drudis.2018.08.001_bib0140","first-page":"109","article-title":"The calcium uniporter regulates the permeability transition pore in isolated cortical mitochondria","volume":"7","author":"Yu","year":"2012","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.drudis.2018.08.001_bib0145","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1038\/nature03317","article-title":"Cyclophilin D-dependent mitochondrial permeability transition regulates some necrotic but not apoptotic cell death","volume":"434","author":"Nakagawa","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2018.08.001_bib0150","doi-asserted-by":"crossref","first-page":"12005","DOI":"10.1073\/pnas.0505294102","article-title":"Cyclophilin D is a component of mitochondrial permeability transition and mediates neuronal cell death after focal cerebral ischemia","volume":"102","author":"Schinzel","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.drudis.2018.08.001_bib0155","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.molcel.2015.08.009","article-title":"SPG7 is an essential and conserved component of the mitochondrial permeability transition pore","volume":"60","author":"Shanmughapriya","year":"2015","journal-title":"Mol. Cell"},{"key":"10.1016\/j.drudis.2018.08.001_bib0160","doi-asserted-by":"crossref","first-page":"7558","DOI":"10.1073\/pnas.0702228104","article-title":"Cyclophilin D inactivation protects axons in experimental autoimmune encephalomyelitis, an animal model of multiple sclerosis","volume":"104","author":"Forte","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.drudis.2018.08.001_bib0165","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1124\/jpet.109.153213","article-title":"Mitochondrial permeability transition pore opening as a promising therapeutic target in cardiac diseases","volume":"330","author":"Javadov","year":"2009","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.drudis.2018.08.001_bib0170","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/nature02229","article-title":"The ADP\/ATP translocator is not essential for the mitochondrial permeability transition pore","volume":"427","author":"Kokoszka","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2018.08.001_bib0175","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.biocel.2010.01.004","article-title":"Mitochondrial medicine for neurodegenerative diseases","volume":"42","author":"Du","year":"2010","journal-title":"Int. J. Biochem. Cell. Biol."},{"key":"10.1016\/j.drudis.2018.08.001_bib0180","first-page":"2003","article-title":"Oxidative stress, mitochondrial damage and neurodegenerative diseases","volume":"8","author":"Guo","year":"2013","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.drudis.2018.08.001_bib0185","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1038\/nm.1868","article-title":"Cyclophilin D deficiency attenuates mitochondrial and neuronal perturbation and ameliorates learning and memory in Alzheimer\u2019s disease","volume":"14","author":"Du","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.drudis.2018.08.001_bib0190","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1152\/physrev.1999.79.4.1127","article-title":"Mitochondrial transport of cations: channels, exchangers, and permeability transition","volume":"79","author":"Bernardi","year":"1999","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.drudis.2018.08.001_bib0195","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1083\/jcb.153.2.319","article-title":"Cytochrome c maintains mitochondrial transmembrane potential and ATP generation after outer mitochondrial membrane permeabilization during the apoptotic process","volume":"153","author":"Waterhouse","year":"2001","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.drudis.2018.08.001_bib0200","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1080\/01926230701320337","article-title":"Apoptosis: a review of programmed cell death","volume":"35","author":"Elmore","year":"2007","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.drudis.2018.08.001_bib0205","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/nrm3737","article-title":"Regulated necrosis: the expanding network of non-apoptotic cell death pathways","volume":"15","author":"Vanden Berghe","year":"2014","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.drudis.2018.08.001_bib0210","doi-asserted-by":"crossref","first-page":"a006189","DOI":"10.1101\/cshperspect.a006189","article-title":"Neuropathological alterations in Alzheimer disease","volume":"1","author":"Serrano-Pozo","year":"2011","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.drudis.2018.08.001_bib0215","doi-asserted-by":"crossref","first-page":"451","DOI":"10.2119\/2007-00100.Irvine","article-title":"Protein aggregation in the brain: the molecular basis for Alzheimer\u2019s and Parkinson\u2019s diseases","volume":"14","author":"Irvine","year":"2008","journal-title":"Mol. Med."},{"key":"10.1016\/j.drudis.2018.08.001_bib0220","doi-asserted-by":"crossref","first-page":"55","DOI":"10.4103\/0019-5545.44908","article-title":"Neurobiology of Alzheimer\u2019s disease","volume":"51","author":"Mohandas","year":"2009","journal-title":"Indian J. Psychiatry"},{"key":"10.1016\/j.drudis.2018.08.001_bib0225","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1523\/JNEUROSCI.4717-10.2011","article-title":"Inhibition of amyloid-beta (Abeta) peptide-binding alcohol dehydrogenase-Abeta interaction reduces Abeta accumulation and improves mitochondrial function in a mouse model of Alzheimer\u2019s disease","volume":"31","author":"Yao","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.drudis.2018.08.001_bib0230","doi-asserted-by":"crossref","first-page":"780179","DOI":"10.1155\/2014\/780179","article-title":"Mitochondrial dysfunction: different routes to Alzheimer\u2019s disease therapy","volume":"2014","author":"Picone","year":"2014","journal-title":"Oxid. Med. Cell Longev."},{"key":"10.1016\/j.drudis.2018.08.001_bib0235","doi-asserted-by":"crossref","first-page":"13145","DOI":"10.1073\/pnas.0806192105","article-title":"The amyloid beta-peptide is imported into mitochondria via the TOM import machinery and localized to mitochondrial cristae","volume":"105","author":"Hansson Petersen","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.drudis.2018.08.001_bib0240","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.steroids.2006.05.003","article-title":"The spirostenol (22R, 25R)-20alpha-spirost-5-en-3beta-yl hexanoate blocks mitochondrial uptake of Abeta in neuronal cells and prevents Abeta-induced impairment of mitochondrial function","volume":"71","author":"Tillement","year":"2006","journal-title":"Steroids"},{"key":"10.1016\/j.drudis.2018.08.001_bib0245","doi-asserted-by":"crossref","first-page":"30317","DOI":"10.1074\/jbc.M112.365890","article-title":"Swedish Alzheimer mutation induces mitochondrial dysfunction mediated by HSP60 mislocalization of amyloid precursor protein (APP) and beta-amyloid","volume":"287","author":"Walls","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drudis.2018.08.001_bib0250","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1096\/fj.04-2582fje","article-title":"ABAD enhances Abeta-induced cell stress via mitochondrial dysfunction","volume":"19","author":"Takuma","year":"2005","journal-title":"FASEB J."},{"key":"10.1016\/j.drudis.2018.08.001_bib0255","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1126\/science.1091230","article-title":"ABAD directly links Abeta to mitochondrial toxicity in Alzheimer\u2019s disease","volume":"304","author":"Lustbader","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.drudis.2018.08.001_bib0260","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3233\/JAD-2007-12208","article-title":"Amyloid-beta-induced mitochondrial dysfunction","volume":"12","author":"Chen","year":"2007","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.drudis.2018.08.001_bib0265","doi-asserted-by":"crossref","first-page":"5685","DOI":"10.1074\/jbc.M707932200","article-title":"Endophilin I expression is increased in the brains of Alzheimer disease patients","volume":"283","author":"Ren","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drudis.2018.08.001_bib0270","doi-asserted-by":"crossref","first-page":"28913","DOI":"10.1074\/jbc.M103198200","article-title":"Endophilin regulates JNK activation through its interaction with the germinal center kinase-like kinase","volume":"276","author":"Ramjaun","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drudis.2018.08.001_bib0275","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1007\/s10571-009-9398-y","article-title":"Amyloid-beta leads to impaired cellular respiration, energy production and mitochondrial electron chain complex activities in human neuroblastoma cells","volume":"29","author":"Rhein","year":"2009","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.drudis.2018.08.001_bib0280","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.mito.2013.03.008","article-title":"Mitochondrial respiratory chain Complexes I and IV are impaired by beta-amyloid via direct interaction and through Complex I-dependent ROS production, respectively","volume":"13","author":"Bobba","year":"2013","journal-title":"Mitochondrion"},{"key":"10.1016\/j.drudis.2018.08.001_bib0285","doi-asserted-by":"crossref","first-page":"3233","DOI":"10.1093\/brain\/awx258","article-title":"PINK1 signalling rescues amyloid pathology and mitochondrial dysfunction in Alzheimer\u2019s disease","volume":"140","author":"Du","year":"2017","journal-title":"Brain"},{"key":"10.1016\/j.drudis.2018.08.001_bib0290","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3233\/JAD-170283","article-title":"Mitochondrial dysfunction triggers synaptic deficits via activation of p38 MAP kinase signaling in differentiated Alzheimer\u2019s disease trans-mitochondrial cybrid cells","volume":"59","author":"Yu","year":"2017","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.drudis.2018.08.001_bib0295","doi-asserted-by":"crossref","first-page":"679","DOI":"10.3233\/JAD-160532","article-title":"Antioxidants rescue mitochondrial transport in differentiated Alzheimer\u2019s disease trans-mitochondrial cybrid cells","volume":"54","author":"Yu","year":"2016","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.drudis.2018.08.001_bib0300","doi-asserted-by":"crossref","first-page":"571","DOI":"10.3233\/JAD-150917","article-title":"Increased electron paramagnetic resonance signal correlates with mitochondrial dysfunction and oxidative stress in an Alzheimer\u2019s disease mouse brain","volume":"51","author":"Fang","year":"2016","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.drudis.2018.08.001_bib0305","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.bbrc.2015.11.022","article-title":"Blockade of Drp1 rescues oxidative stress-induced osteoblast dysfunction","volume":"468","author":"Gan","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.drudis.2018.08.001_bib0310","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s00709-015-0930-2","article-title":"Mitochondrial permeability transition pore: a promising target for the treatment of Parkinson\u2019s disease","volume":"254","author":"Rasheed","year":"2017","journal-title":"Protoplasma"},{"key":"10.1016\/j.drudis.2018.08.001_bib0315","doi-asserted-by":"crossref","first-page":"a009399","DOI":"10.1101\/cshperspect.a009399","article-title":"alpha-Synuclein in Parkinson\u2019s disease","volume":"2","author":"Stefanis","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.drudis.2018.08.001_bib0320","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1046\/j.1471-4159.1999.0731127.x","article-title":"Dopamine oxidation alters mitochondrial respiration and induces permeability transition in brain mitochondria: implications for Parkinson\u2019s disease","volume":"73","author":"Berman","year":"1999","journal-title":"J. Neurochem."},{"key":"10.1016\/j.drudis.2018.08.001_bib0325","doi-asserted-by":"crossref","unstructured":"(1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes. The Huntington\u2019s Disease Collaborative Research Group. Cell 72, 971\u2013983","DOI":"10.1016\/0092-8674(93)90585-E"},{"key":"10.1016\/j.drudis.2018.08.001_bib0330","doi-asserted-by":"crossref","first-page":"4858","DOI":"10.1523\/JNEUROSCI.23-12-04858.2003","article-title":"Increased susceptibility of striatal mitochondria to calcium-induced permeability transition","volume":"23","author":"Brustovetsky","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.drudis.2018.08.001_bib0335","doi-asserted-by":"crossref","first-page":"34785","DOI":"10.1074\/jbc.M603845200","article-title":"Mutant huntingtin expression induces mitochondrial calcium handling defects in clonal striatal cells: functional consequences","volume":"281","author":"Milakovic","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drudis.2018.08.001_bib0340","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1172\/JCI26274","article-title":"Mitochondria: pharmacological manipulation of cell death","volume":"115","author":"Bouchier-Hayes","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.drudis.2018.08.001_bib0345","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/bs.pmbts.2016.12.019","article-title":"Mitochondrial perturbation in Alzheimer\u2019s disease and diabetes","volume":"146","author":"Akhter","year":"2017","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"10.1016\/j.drudis.2018.08.001_bib0350","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1016\/j.bbadis.2015.07.019","article-title":"NR2B-dependent cyclophilin D translocation suppresses the recovery of synaptic transmission after oxygen-glucose deprivation","volume":"1852","author":"Zhang","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.drudis.2018.08.001_bib0355","doi-asserted-by":"crossref","first-page":"5198","DOI":"10.1093\/hmg\/ddv241","article-title":"Increased neuronal PreP activity reduces Abeta accumulation, attenuates neuroinflammation and improves mitochondrial and synaptic function in Alzheimer disease\u2019s mouse model","volume":"24","author":"Fang","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.drudis.2018.08.001_bib0360","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.bbadis.2013.11.009","article-title":"Inhibition of ERK-DLP1 signaling and mitochondrial division alleviates mitochondrial dysfunction in Alzheimer\u2019s disease cybrid cell","volume":"1842","author":"Gan","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.drudis.2018.08.001_bib0365","article-title":"Cyclophilin D deficiency rescues axonal mitochondrial transport in Alzheimer\u2019s neurons","volume":"8","author":"Guo","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.drudis.2018.08.001_bib0370","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1016\/j.bbadis.2013.03.004","article-title":"Cyclophilin D deficiency rescues Abeta-impaired PKA\/CREB signaling and alleviates synaptic degeneration","volume":"1842","author":"Du","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.drudis.2018.08.001_bib0375","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.freeradbiomed.2014.07.021","article-title":"Oxidative stress-mediated activation of extracellular signal-regulated kinase contributes to mild cognitive impairment-related mitochondrial dysfunction","volume":"75","author":"Gan","year":"2014","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.drudis.2018.08.001_bib0380","doi-asserted-by":"crossref","first-page":"18670","DOI":"10.1073\/pnas.1006586107","article-title":"Early deficits in synaptic mitochondria in an Alzheimer\u2019s disease mouse model","volume":"107","author":"Du","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.drudis.2018.08.001_bib0385","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.arr.2010.05.003","article-title":"Modulation of mitochondrial calcium as a pharmacological target for Alzheimer\u2019s disease","volume":"9","author":"Hung","year":"2010","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.drudis.2018.08.001_bib0390","first-page":"106","article-title":"Mitochondria-targeted antioxidants as therapies","volume":"11","author":"Smith","year":"2011","journal-title":"Discov. Med."},{"key":"10.1016\/j.drudis.2018.08.001_bib0395","doi-asserted-by":"crossref","first-page":"4356","DOI":"10.1074\/jbc.M115.700385","article-title":"Selective inhibition of the mitochondrial permeability transition pore protects against neurodegeneration in experimental multiple sclerosis","volume":"291","author":"Warne","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drudis.2018.08.001_bib0400","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1089\/ars.2010.3849","article-title":"Mitochondrial permeability transition pore component cyclophilin D distinguishes nigrostriatal dopaminergic death paradigms in the MPTP mouse model of Parkinson\u2019s disease","volume":"16","author":"Thomas","year":"2012","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.drudis.2018.08.001_bib0405","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.expneurol.2009.02.007","article-title":"Role of cyclophilin D-dependent mitochondrial permeability transition in glutamate-induced calcium deregulation and excitotoxic neuronal death","volume":"218","author":"Li","year":"2009","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.drudis.2018.08.001_bib0410","doi-asserted-by":"crossref","first-page":"308","DOI":"10.3949\/ccjm.61.4.308","article-title":"Cyclosporine: mechanisms of action and toxicity","volume":"61","author":"Graham","year":"1994","journal-title":"Cleve. Clin. J. Med."},{"key":"10.1016\/j.drudis.2018.08.001_bib0415","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1136\/jcp.37.10.1167","article-title":"Distribution and concentration of cyclosporin in human blood","volume":"37","author":"Atkinson","year":"1984","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.drudis.2018.08.001_bib0420","doi-asserted-by":"crossref","first-page":"12777","DOI":"10.1038\/ncomms12777","article-title":"Fragment-based discovery of a new family of non-peptidic small-molecule cyclophilin inhibitors with potent antiviral activities","volume":"7","author":"Ahmed-Belkacem","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.drudis.2018.08.001_bib0425","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1021\/ci5000196","article-title":"Structure based design, synthesis, pharmacophore modeling, virtual screening, and molecular docking studies for identification of novel cyclophilin D inhibitors","volume":"54","author":"Valasani","year":"2014","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.drudis.2018.08.001_bib0430","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1021\/ci400196z","article-title":"Acetylcholinesterase inhibitors: structure based design, synthesis, pharmacophore modeling, and virtual screening","volume":"53","author":"Valasani","year":"2013","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.drudis.2018.08.001_bib0435","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1021\/acsmedchemlett.5b00451","article-title":"Identification of a small molecule cyclophilin D inhibitor for rescuing abeta-mediated mitochondrial dysfunction","volume":"7","author":"Valasani","year":"2016","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.drudis.2018.08.001_bib0440","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1111\/j.1745-7254.2005.00189.x","article-title":"Novel cyclophilin D inhibitors derived from quinoxaline exhibit highly inhibitory activity against rat mitochondrial swelling and Ca2+ uptake\/release","volume":"26","author":"Guo","year":"2005","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.drudis.2018.08.001_bib0445","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.ejmech.2014.07.027","article-title":"Novel quinazoline-urea analogues as modulators for Abeta-induced mitochondrial dysfunction: design, synthesis, and molecular docking study","volume":"84","author":"Elkamhawy","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.drudis.2018.08.001_bib0450","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ejphar.2014.01.021","article-title":"JM-20, a novel benzodiazepine-dihydropyridine hybrid molecule, protects mitochondria and prevents ischemic insult-mediated neural cell death in vitro","volume":"726","author":"Nunez-Figueredo","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.drudis.2018.08.001_bib0455","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.brainresbull.2014.10.001","article-title":"Antioxidant effects of JM-20 on rat brain mitochondria and synaptosomes: mitoprotection against Ca2+-induced mitochondrial impairment","volume":"109","author":"Nunez-Figueredo","year":"2014","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.drudis.2018.08.001_bib0460","doi-asserted-by":"crossref","first-page":"433","DOI":"10.3389\/fncel.2014.00433","article-title":"GNX-4728, a novel small molecule drug inhibitor of mitochondrial permeability transition, is therapeutic in a mouse model of amyotrophic lateral sclerosis","volume":"8","author":"Martin","year":"2014","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.drudis.2018.08.001_bib0465","doi-asserted-by":"crossref","first-page":"422","DOI":"10.2174\/1567205011666140505094808","article-title":"Dimebon attenuates the Abeta-induced mitochondrial permeabilization","volume":"11","author":"Shevtsova","year":"2014","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.drudis.2018.08.001_bib0470","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/j.1460-9568.2007.05663.x","article-title":"Nortriptyline delays disease onset in models of chronic neurodegeneration","volume":"26","author":"Wang","year":"2007","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.drudis.2018.08.001_bib0475","doi-asserted-by":"crossref","first-page":"102","DOI":"10.2174\/1871527314666150821111812","article-title":"Neuroprotective effects of the securinine-analogues: identification of allomargaritarine as a lead compound","volume":"15","author":"Neganova","year":"2016","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.drudis.2018.08.001_bib0480","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1042\/BJ20090332","article-title":"Mitochondrial targeting of cyclosporin A enables selective inhibition of cyclophilin-D and enhanced cytoprotection after glucose and oxygen deprivation","volume":"425","author":"Malouitre","year":"2009","journal-title":"Biochem. J."},{"key":"10.1016\/j.drudis.2018.08.001_bib0485","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1042\/BJ20111301","article-title":"A mitochondrial-targeted cyclosporin A with high binding affinity for cyclophilin D yields improved cytoprotection of cardiomyocytes","volume":"441","author":"Dube","year":"2012","journal-title":"Biochem. J."},{"issue":"Suppl. 1","key":"10.1016\/j.drudis.2018.08.001_bib0490","first-page":"69","article-title":"The value of plants used in traditional medicine for drug discovery","volume":"109","author":"Fabricant","year":"2001","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.drudis.2018.08.001_bib0495","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1080\/10286020.2010.544253","article-title":"Protective effect of curcumin (Curcuma longa) against d-galactose-induced senescence in mice","volume":"13","author":"Kumar","year":"2011","journal-title":"J. Asian Nat. Prod. Res."},{"key":"10.1016\/j.drudis.2018.08.001_bib0500","doi-asserted-by":"crossref","first-page":"9859","DOI":"10.3390\/ijms15069859","article-title":"Ginsenoside Rd attenuates mitochondrial permeability transition and cytochrome C release in isolated spinal cord mitochondria: involvement of kinase-mediated pathways","volume":"15","author":"Zhou","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.drudis.2018.08.001_bib0505","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1080\/10715760802571988","article-title":"Curcuminoids modulates oxidative damage and mitochondrial dysfunction in diabetic rat brain","volume":"42","author":"Rastogi","year":"2008","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.drudis.2018.08.001_bib0510","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.phrs.2007.09.011","article-title":"Stabilization of mitochondrial function by Ginkgo biloba extract (EGb 761)","volume":"56","author":"Abdel-Kader","year":"2007","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.drudis.2018.08.001_bib0515","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.2174\/0929867311320130008","article-title":"Multitarget drugs of plants origin acting on Alzheimer\u2019s disease","volume":"20","author":"Russo","year":"2013","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.drudis.2018.08.001_bib0520","doi-asserted-by":"crossref","first-page":"3670","DOI":"10.1016\/j.bbagen.2013.02.008","article-title":"Natural products: a continuing source of novel drug leads","volume":"1830","author":"Cragg","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.drudis.2018.08.001_bib0525","doi-asserted-by":"crossref","first-page":"6846","DOI":"10.1021\/ja00388a092","article-title":"Isolation and structures of bryostatin-1","volume":"104","author":"Pettit","year":"1982","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.drudis.2018.08.001_bib0530","doi-asserted-by":"crossref","first-page":"22","DOI":"10.2174\/1567205012666141218141904","article-title":"Acute oral Bryostatin-1 administration improves learning deficits in the APP\/PS1 transgenic mouse model of Alzheimer\u2019s disease","volume":"12","author":"Schrott","year":"2015","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.drudis.2018.08.001_bib0535","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/S0891-5849(96)00351-6","article-title":"Antioxidant and prooxidant behavior of flavonoids: structure-activity relationships","volume":"22","author":"Cao","year":"1997","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.drudis.2018.08.001_bib0540","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1021\/tx980271b","article-title":"Glutathione-dependent generation of reactive oxygen species by the peroxidase-catalysed redox cycling of flavonoids","volume":"12","author":"Galati","year":"1999","journal-title":"Chem. Res. Toxicol."}],"container-title":["Drug Discovery Today"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644617302489?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644617302489?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T12:36:27Z","timestamp":1761222987000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359644617302489"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":108,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["S1359644617302489"],"URL":"https:\/\/doi.org\/10.1016\/j.drudis.2018.08.001","relation":{},"ISSN":["1359-6446"],"issn-type":[{"value":"1359-6446","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mitochondrial permeability transition pore: a potential drug target for neurodegeneration","name":"articletitle","label":"Article Title"},{"value":"Drug Discovery Today","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drudis.2018.08.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}